Effect of YM435, a Dopamine DA 1 Receptor Agonist, in a Canine Model of Ischemic Acute Renal Failure - an update of dopamine and a first look at dobutamine

By Yatsu T.   Arai Y.   Takizawa K.   Kasai-Nakagawa C.   Takanashi M.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 803-807

Elsevier

Access to resources Recommend Favorite

Renal effect of YM435, a new dopamine D 1 receptor agonist, in anesthetized dogs

By Yatsu T.   Arai Y.   Takizawa K.   Kasai-Nakagawa C.   Takanashi M.   Uchida W.   Inagaki O.   Tanaka A.   Asano M.   Honda K.   Takenaka T.  

European Journal of Pharmacology, Vol. 322, Iss. 1, 1997-03 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Effects of YM 435 and A 77636 on Dopamine D-1 Receptors in Bovine Retina In Vitro

By Ofori S.   De Raad S.   Bugnon O.   Schorderet M.  

General Pharmacology, Vol. 26, Iss. 1, 1995-01 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats

By Yatsu T.   Aoki M.   Inagaki O.  

European Journal of Pharmacology, Vol. 461, Iss. 2, 2003-02 ,pp. : 191-195

Elsevier

Access to resources Recommend Favorite

D 1 Agonist and/or D 2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure-activity study

By Mantegani S.   Arlandini E.   Bandiera T.   Borghi D.   Brambilla E.   Caccia C.   Cervini M.A.   Cremonesi P.   McArthur R.A.   Traquandi G.   Varasi M.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 2, 1999-02 ,pp. : 107-124

Elsevier

Access to resources Recommend Favorite